Home > Products > gp40 & TFRC
> Recombinant Anti-gp40 x Anti-TFRC Bispecific Antibody (scIgG)
Recombinant Anti-gp40 x Anti-TFRC Bispecific Antibody (scIgG) (CAT#: SCIGG-164)
Recombinant Anti-gp40 x Anti-TFRC Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-gp40 and anti-TFRC IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can bind two tumor antigens simultaneously. It is designed for the research of Colon cancer; Ovarian cancer therapy.
There are currently no customer reviews or questions for Recombinant Anti-gp40 x Anti-TFRC Bispecific Antibody (scIgG) (SCIGG-164). Click the button below to contact us or submit your feedback about this product.